Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Men and women experience skin aging differently due to changes in sex hormone levels with age.